Lydia Kalafateli| Investment Manager | BOM NL
Lydia is currently an Investment Manager in the Life Sciences & Medtech team at BOM, investing in innovative technologies. Previously, she led venture creation and deal structuring in the biotech team of NLC Health Ventures. During that time, she co-founded a therapeutics startup in the metabolic diseases space, acting as Entrepreneur in Residence during pre-seed fundraising. She began her career at AstraZeneca driving novel drug discovery programmes. Lydia holds an MSc in Pharmacology, a PhD in Neuroscience and an MBA.
About BOM
We are a public enterprise with no commercial interest. That’s why we can enter where others remain outside. We invest with our own funds and together with more than 150 co-investors. With over €750 million in assets under management, we are the most active investor in Dutch startups.
We build strong ecosystems: bringing together entrepreneurs, knowledge institutes, and governments to get innovation off the ground faster. Our venture building programs provide direction and momentum for growth. And we open international doors for companies looking to expand or establish themselves in Brabant.
| Powered by: Hyphen Projects | Connect | Join Global Investor Forum | |||
| Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 |
|
REGISTER NOW
SUBSCRIBE TO OUR NEWSLETTER
|
© Copyright 2025 by Hyphen Projects